Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b studySéverine Vermeire, Bruce E. Sands, Laurent Peyrin-Biroulet et al.|Journal of Crohn s and Colitis|2025Cited by 10
130 Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)Bruce E. Sands, Séverine Vermeire, Silvio Danese et al.|The American Journal of Gastroenterology|2025Cited by 1
Non-interventional post-marketing safety study on the long-term safety of HyQvia (global)Lina Morales Laguado, Leman Yel, András Nagy et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2018Cited by 0